New-onset diabetes after kidney transplantation: risk factors.
about
Role of dipeptidyl peptidase-4 inhibitors in new-onset diabetes after transplantationNew-onset diabetes mellitus after kidney transplantation: Current status and future directionsBody mass index and outcome in renal transplant recipients: a systematic review and meta-analysisMechanisms of diabetes mellitus induced with FK506 in SD rats models.Continuous glucose monitoring in subjects after simultaneous pancreas-kidney and kidney-alone transplantationThe effect of intensive nutrition interventions on weight gain after kidney transplantation: protocol of a randomised controlled trial.New-onset diabetes and glucose regulation are significant determinants of left ventricular hypertrophy in renal transplant recipients.Characterization of Remitting and Relapsing Hyperglycemia in Post-Renal-Transplant Recipients.Changes in Pre- and Post-Exercise Gene Expression among Patients with Chronic Kidney Disease and Kidney Transplant Recipients.Ghrelin contributes to derangements of glucose metabolism induced by rapamycin in miceObesity impacts access to kidney transplantation.Left ventricular torsion changes post kidney transplantation.Mediterranean style diet is associated with low risk of new-onset diabetes after renal transplantation.Metabolic syndrome and solid-organ transplantation.Effects of metformin on hyperglycemia in an experimental model of tacrolimus- and sirolimus-induced diabetic rats.Update on cytomegalovirus infections of the gastrointestinal system in solid organ transplant recipients.New-onset diabetes after kidney transplant in children.Diabetes mellitus in the transplanted kidney.The impact of cytomegalovirus infection on new-onset diabetes mellitus after kidney transplantation: a review on current findings.Protocol for a pilot randomised controlled trial of metformin in pre-diabetes after kidney transplantation: the Transplantation and Diabetes (Transdiab) study.For Vascularized Composite Allografts: The Elephant in the Room.Hypomagnesemia linked to new-onset diabetes mellitus after kidney transplantation: A systematic review and meta-analysis.Genetic factors in pathogenesis of diabetes mellitus after kidney transplantation.A low-risk ZnT-8 allele (W325) for post-transplantation diabetes mellitus is protective against cyclosporin A-induced impairment of insulin secretion.Pre-transplant weight but not weight gain is associated with new-onset diabetes after transplantation: a multi-centre cohort Spanish studyNew-Onset Diabetes After Kidney Transplantation and Pretransplant Hypomagnesemia.CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantation.Effect of an intensive nutrition intervention of a high protein and low glycemic-index diet on weight of kidney transplant recipients: study protocol for a randomized clinical trial.Post-renal transplant diabetes mellitus in korean subjects: superimposition of transplant-related immunosuppressant factors on genetic and type 2 diabetic risk factorsA randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation.Single-dose rATG induction at renal transplantation: superior renal function and glucoregulation with less hypomagnesemia.New onset diabetes after kidney transplantation in autosomal dominant polycystic kidney disease: a retrospective cohort study.Risk factors for development of new-onset diabetes mellitus after transplant in adult lung transplant recipients.Effect of Empagliflozin on Tacrolimus-Induced Pancreas Islet Dysfunction and Renal Injury.The Prevalence of New Onset Diabetes Mellitus after Renal Transplantation in Patients with Immediate Posttransplant Hyperglycemia in a Tertiary Care Centre.New-onset diabetes after kidney transplantation: can the risk be modified by choosing immunosuppression regimen based on pretransplant viral serology?The effect of magnesium supplements on early post-transplantation glucose metabolism: a randomized controlled trial.Improving Medication Safety and Cardiovascular Risk Factor Control to Mitigate Disparities in African-American Kidney Transplant Recipients: Design and Methods.Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.
P2860
Q26778329-97513157-D966-4DC8-BA83-B94AA9DCEEC1Q28083882-49F0E44E-2895-48E4-9489-BBEC1B7576C3Q28085010-F6FB56BA-5DEC-4BE4-BD34-B490930BA730Q33513711-E3F909F1-CE58-4D54-8024-D6141899445FQ33905182-EFE50F4A-3466-43A9-9B75-833CCF38A206Q34252261-4D1F86C0-D14A-425E-8335-E9BACA6FF33EQ35508630-74C6430C-B739-4E2D-BAB7-30E92627A324Q35836067-60C6CFA3-E602-42B1-AB04-DE9E1E3A684DQ36102736-90DEE0A2-0A0F-4F9B-8DD2-64D3655262E5Q36393621-7179EEA3-F6CE-4F21-A910-5E2340BCF3F5Q36677404-0BE088E3-091B-4BE8-87C8-02469454DA8FQ37488605-9D0A336B-86EF-436A-8EC9-F0488B0BADE3Q37598026-CC86C266-C170-42E1-BB6C-CF0ED9E30EF5Q37643770-75AA439B-CD99-4021-A36E-81EE28D8A040Q37683441-4FCB41CC-BECE-4015-9DC2-6147B73814D3Q37962447-756948D3-8AC3-468D-90BB-FF4093FA1E5CQ38217406-5BB6D15F-6ECE-4624-84BC-005927F94388Q38249183-AC20BF54-892A-42C4-BEBF-D160512896FFQ38265561-9F6AE8F5-DD28-43D0-93D7-538BBC543B41Q38609525-8D1C981E-A7FE-45C5-8520-697018CB9513Q38694170-B4B9A474-9A53-4EBD-94C4-D8C0112A17A8Q38757830-729681D7-45A6-4010-A1DC-2FDDAE60C60EQ39257633-35CCB87C-F38B-4904-A75E-C819C8115196Q39721171-27E36106-E27C-4419-AD22-3E456C111175Q40704939-26BCA765-156E-44C5-8F3D-E43377832344Q40773018-C4381AED-E0AD-4FB6-A9F7-6761B5DFF689Q40880029-C70C368D-BC71-40D1-B684-19339F41C6BEQ41625001-E454CD71-DF9C-49BD-9505-33EDB108DD38Q42209549-6ECB6E3A-5974-40E6-89C3-E006D080A09EQ42357002-ECD92FE5-E9FD-4659-BEE0-0B45BB62362DQ43485090-8D30A503-7091-499E-89FE-6A1BBE810BA7Q46050159-5B50D491-5A0B-4367-93B1-22666529C1AEQ46364896-AD0729C8-892F-41E6-9348-A80C74048DA3Q46380921-1F80CF09-053E-4FA6-87BE-4CA3B65D4A9EQ47559840-B75874B0-9904-4610-8D79-7856179BD5BFQ47608460-88A6EF42-2C98-426F-BD15-CCA4088E4BE7Q49065233-80633FDB-10A5-4467-B163-E05D78E00A05Q54941607-173D7754-9F8C-4E8D-8922-0F4E9C949587Q55501318-EBBB4147-BED5-4561-8B35-13E0F5AE6965
P2860
New-onset diabetes after kidney transplantation: risk factors.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
New-onset diabetes after kidney transplantation: risk factors.
@ast
New-onset diabetes after kidney transplantation: risk factors.
@en
type
label
New-onset diabetes after kidney transplantation: risk factors.
@ast
New-onset diabetes after kidney transplantation: risk factors.
@en
prefLabel
New-onset diabetes after kidney transplantation: risk factors.
@ast
New-onset diabetes after kidney transplantation: risk factors.
@en
P2093
P356
P1476
New-onset diabetes after kidney transplantation: risk factors
@en
P2093
Carlos Gómez-Alamillo
Celestino Piñera
Emilio Rodrigo
Gema Fernández-Fresnedo
Julio González-Cotorruelo
Manuel Arias
Rosa Palomar
Rosalía Valero
P304
P356
10.1681/ASN.2006080929
P433
12 Suppl 3
P50
P577
2006-12-01T00:00:00Z